Table 1. Significant genetic correlations between lung function measures and metabolite and hormone GWAS.
Lung function trait | Biochemical trait | Genetic correlation (rg)* | p-Value |
---|---|---|---|
FEV1 | Fasting insulin | −0.23 (0.04) | 6.61 × 10−8 |
Leptin (BMI unadjusted) | −0.25 (0.05) | 3.74 × 10−7 | |
Leptin (BMI adjusted) | −0.24 (0.05) | 9.13 × 10−7 | |
Urate | −0.12 (0.03) | 9.46 × 10−6 | |
Fasting glucose | −0.13 (0.03) | 1 × 10−4 | |
FVC | Fasting insulin | −0.31 (0.04) | 6.98 × 10−14 |
Leptin (BMI unadjusted) | −0.33 (0.05) | 2.85 × 10−12 | |
Leptin (BMI adjusted) | −0.27 (0.05) | 1.21 × 10−8 | |
HDL cholesterol | 0.14 (0.03) | 9.97 × 10−7 | |
Urate | −0.12 (0.02) | 9.54 × 10−7 | |
Triglycerides | −0.11 (0.03) | 1.53 × 10−5 | |
Fasting glucose | −0.12 (0.03) | 1 × 10−4 | |
FEV1/FVC | HDL cholesterol | −0.11 (0.03) | 2 × 10−4 |
*Genetic correlations which survived multiple testing correction for each lung function trait individually are reported with their respective standard error.
Evidence of a causal relationship between fasting glucose and lung function supports antihyperglycaemic compounds as drug-repurposing candidates.
FEV1: forced expiratory volume in 1 s; FVC: forced vital capacity; FEV1/FVC: ratio of FEV1 to FVC; HDL: high-density lipoprotein; BMI: body mass index; GWAS: genome-wide association studies.